Adalimumab-aacf Kit
Product Images NDC 65219-620

122 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 122 technical images submitted to the FDA as part of the official labeling for Adalimumab-aacf (NDC 65219-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Ada08 0006 01)

Figure A (Ada08 0006 01)
An illustrated diagram showing the components of the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC. It includes a vial, vial adapter, alcohol prep pads, needle, and a syringe, each labeled clearly and depicted separately on a white background.*
FDA Label Image

Figure B (Ada08 0006 02)

Figure B (Ada08 0006 02)
An instructional illustration showing a close-up of hands peeling back the protective cover of a medical device or injector, likely related to the administration of a subcutaneous drug from a kit.*
FDA Label Image

Figure C (Ada08 0006 03)

Figure C (Ada08 0006 03)
An instructional illustration showing hands manipulating a subcutaneous injection device, specifically a vial being prepared for use with a finger pressing on a component, accompanied by a downward pointing arrow indicating a step in the preparation or administration process.*
FDA Label Image

Figure D (Ada08 0006 04)

Figure D (Ada08 0006 04)
An instructional illustration showing hands manipulating a small medical component, likely part of a subcutaneous injection kit. The image demonstrates how to remove or adjust a clear plastic cap from a device, highlighting the step-by-step process with an arrow indicating upward movement and a close-up inset for detail.*
FDA Label Image

Figure E (Ada08 0006 05)

Figure E (Ada08 0006 05)
An instructional illustration showing hands preparing a vial and syringe for injection. The close-up highlights the turning motion to withdraw medication from the vial, indicating a step in preparing a subcutaneous injection kit.*
FDA Label Image

Figure F (Ada08 0006 06)

Figure F (Ada08 0006 06)
An instructional illustration showing two hands demonstrating the use of a syringe with a blue arrow indicating a twisting or turning motion, likely related to preparing or administering the medication Adalimumab-aacf.*
FDA Label Image

Figure G (Ada08 0006 07)

Figure G (Ada08 0006 07)
An instructional illustration showing a hand holding a syringe and the syringe barrel with a close-up of the measurement markings. The diagram emphasizes proper measurement of a liquid dose in milliliters, ranging from 0.1 to 0.5 mL, for subcutaneous administration.*
FDA Label Image

Figure H (Ada08 0006 08)

Figure H (Ada08 0006 08)
An instructional illustration showing two hands interacting with a drug device presumably from the Adalimumab-aacf kit. The top hand is holding a component above the other hand holding a container, with a blue arrow indicating a twisting or rotating motion to connect or assemble the parts.*
FDA Label Image

Figure I (Ada08 0006 09)

Figure I (Ada08 0006 09)
An instructional diagram illustrating components of a subcutaneous injection device, including a pink needle cover, textured finger pad, yellow syringe connector, clear needle cap, and outer needle packaging.*
FDA Label Image

Figure J (Ada08 0006 10)

Figure J (Ada08 0006 10)
An illustration showing a close-up of a hand holding a small medical device or component, possibly a needle or syringe cap, with parts in yellow and pink visible. The background is neutral and out of focus.*
FDA Label Image

Figure K (Ada08 0006 11)

Figure K (Ada08 0006 11)
An instructional illustration showing hands holding and preparing a syringe, with a blue circular arrow indicating a twisting or turning motion. The image depicts a step for using a subcutaneous injection kit, likely related to the Adalimumab-aacf product.*
FDA Label Image

Figure L (Ada08 0006 12)

Figure L (Ada08 0006 12)
An instructional illustration showing hands holding a syringe with a needle cap being removed. An upward arrow indicates the direction to pull off the needle cap, demonstrating part of the preparation step for subcutaneous injection.*
FDA Label Image

Figure M (Ada08 0006 13)

Figure M (Ada08 0006 13)
An instructional illustration showing hands preparing a subcutaneous injection by removing a pink protective cap from a needle attached to a syringe. The image demonstrates the step of exposing the needle before administering the medication.*
FDA Label Image

Figure N (Ada08 0006 14)

Figure N (Ada08 0006 14)
An instructional illustration showing hands removing a needle cap from a syringe. The syringe is held upright, and an upward arrow indicates the direction to pull the needle cap off. This image demonstrates proper preparation for a subcutaneous injection.*
FDA Label Image

Figure O (Ada08 0006 15)

Figure O (Ada08 0006 15)
An instructional illustration showing a person removing a pink safety cap from a syringe before use. The image depicts the hand holding the syringe and the cap, demonstrating the step in preparing a subcutaneous injection. The syringe contains a yellow liquid, likely medication.*
FDA Label Image

Figure 1 (Ada08 0006 16)

Figure 1 (Ada08 0006 16)
A line graph comparing the percentage of ACR20 responders over time (weeks) for two groups: "40 mg every other week" represented by solid squares and "Placebo" represented by open circles. The graph shows time on the x-axis (ranging from 0 to 48 weeks) and percent ACR20 responders on the y-axis (ranging from 0 to 70).*
FDA Label Image

Figure (Ada08 0006 17)

Figure (Ada08 0006 17)
A line graph comparing % ACR20 response over 26 weeks between groups receiving Adalimumab and placebo. The vertical axis shows % ACR20 response, and the horizontal axis shows time in weeks. The Adalimumab group shows a higher response percentage over time compared to placebo.*
FDA Label Image

Figure (Ada08 0006 18)

Figure (Ada08 0006 18)
A line graph comparing treatment failure rates over time (up to 20 months) between placebo and Adalimumab treatments. The x-axis represents time in months, and the y-axis represents treatment failure rate percentage. Adalimumab shows a lower and slower increase in failure rate compared to placebo.*
FDA Label Image

Figure (Ada08 0006 19)

Figure (Ada08 0006 19)
A Kaplan-Meier survival curve chart showing treatment failure rates over time (in months) comparing Adalimumab versus placebo groups. The chart depicts cumulative treatment failure percentages on the vertical axis and time in months on the horizontal axis, with data points and number at risk indicated for each group.*
FDA Label Image

Figure (Ada08 0006 20)

Figure (Ada08 0006 20)
Instructions for use illustration showing a single-dose prefilled pen for Adalimumab-aacf, a 40 mg/0.8 mL subcutaneous injection. The image includes the pronunciation guide for adalimumab and identifies the product as IDACIO®, manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 21)

Figure (Ada08 0006 21)
Instructional diagram showing the components and use state of the Adalimumab-aacf subcutaneous injection kit. The 'Before Use' image labels parts such as the needle cap, transparent syringe housing, syringe plunger, label area with dose and expiration, injector body, and injection button. The 'After Use' image shows the needle cap removed, safety guard extended over the needle, and the syringe plunger in its final position.*
FDA Label Image

Figure (Ada08 0006 22)

Figure (Ada08 0006 22)
An instructional illustration titled 'Step 1 Prepare for your injection' displayed on a blue and yellow background, indicating the first step in an injection preparation process for Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 23)

Figure (Ada08 0006 23)
An illustration labeled Figure C showing a red sharps disposal container with a pink lid next to three white cotton balls and a folded white cloth or gauze pad, likely part of an injection kit setup.*
FDA Label Image

Figure (Ada08 0006 24)

Figure (Ada08 0006 24)
An instructional illustration labeled 'Figure D' showing a hand removing a rectangular kit from a refrigerator. The image demonstrates the proper storage or handling step for the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 25)

Figure (Ada08 0006 25)
An illustration labeled 'Figure E' shows a rectangular kit box with a magnified circular inset highlighting the location of the expiration date formatted as 'EXP: YYYY-MM' printed on the box surface.*
FDA Label Image

Figure (Ada08 0006 26)

Figure (Ada08 0006 26)
An instructional illustration showing hands opening a kit by lifting a component upwards. The figure is labeled 'Figure F' and demonstrates part of the preparation or use process for the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 27)

Figure (Ada08 0006 27)
An instructional illustration labeled 'Figure G' showing a hand placing a rectangular kit box into a refrigerator, indicated by a blue arrow pointing towards the refrigerator's interior. This demonstrates proper storage of the product, Adalimumab-aacf kit, under refrigerated conditions.*
FDA Label Image

Figure (Ada08 0006 28)

Figure (Ada08 0006 28)
An instructional illustration labeled 'Figure H' showing a subcutaneous injection device with an icon indicating to wait 30 minutes, featuring a clock graphic with a purple segment marking the 30-minute duration.*
FDA Label Image

Figure (Ada08 0006 29)

Figure (Ada08 0006 29)
An instructional graphic panel labeled 'Step 2' instructing users to wash their hands, featuring blue and yellow text on a blue gradient background.*
FDA Label Image

Figure (Ada08 0006 30)

Figure (Ada08 0006 30)
An instructional illustration showing a person washing their hands under a running faucet. The faucet is curved with water flowing directly onto the hands, indicating a hygiene or handwashing step likely related to the preparation or administration of the Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 31)

Figure (Ada08 0006 31)
An instructional banner labeled 'Step 3 Check your prefilled pen,' likely part of a step-by-step guide for using the Adalimumab-aacf kit containing a subcutaneous prefilled pen.*
FDA Label Image

Figure (Ada08 0006 32)

Figure (Ada08 0006 32)
An instructional diagram showing a transparent syringe housing labeled as Figure J. The image highlights the clear syringe barrel and surrounding housing, likely part of the Adalimumab-aacf kit for subcutaneous administration.*
FDA Label Image

Figure (Ada08 0006 33)

Figure (Ada08 0006 33)
Adalimumab-aacf kit for subcutaneous injection displayed with two different views. The packaging shows the product name, a barcode, lot number, and an expiration date placeholder (EXP: YYYY-MM). It is labeled by Fresenius Kabi USA, LLC and includes a yellow-capped syringe or vial component.*
FDA Label Image

Figure (Ada08 0006 34)

Figure (Ada08 0006 34)
Instructional label panel displaying 'Step 4 Choose the injection site' with a blue and yellow background, likely part of an injection preparation guide for a subcutaneous drug kit.*
FDA Label Image

Figure (Ada08 0006 35)

Figure (Ada08 0006 35)
Illustration showing recommended subcutaneous injection areas for Adalimumab-aacf kit. Target sites include the abdomen around the navel and the front of the thighs, indicating optimal locations for administering the injection.*
FDA Label Image

Figure (Ada08 0006 36)

Figure (Ada08 0006 36)
Instructional graphic labeled Step 5, directing to clean the injection site, with the text displayed on a blue and yellow gradient background.*
FDA Label Image

Figure (Ada08 0006 37)

Figure (Ada08 0006 37)
An instructional illustration labeled 'Figure M' showing a person’s thigh with a hand holding a pen-like device positioned for subcutaneous injection. This likely demonstrates the administration site or technique for the subcutaneous injection of Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 38)

Figure (Ada08 0006 38)
Illustration showing Step 6 of an injection process with the text 'Give your injection' on a blue and yellow background. The image likely guides patients on administering a subcutaneous injection, relevant to adalimumab-aacf kit usage.*
FDA Label Image

Figure (Ada08 0006 39)

Figure (Ada08 0006 39)
Illustration showing a hand removing the cap from a subcutaneous injection device, likely part of the Adalimumab-aacf kit by Fresenius Kabi USA, LLC. The image demonstrates preparation steps for using the medication delivery system.*
FDA Label Image

Figure (Ada08 0006 40)

Figure (Ada08 0006 40)
Illustration showing a hand holding a subcutaneous injection device, which appears to be part of a kit for Adalimumab-aacf (adalimumab). The device includes a grey and yellow handle and a clear plastic tip for administration.*
FDA Label Image

Figure (Ada08 0006 41)

Figure (Ada08 0006 41)
Illustration showing the correct use of the Adalimumab-aacf subcutaneous injection kit. It depicts a hand holding the injection device at a 90-degree angle to the skin. A close-up view highlights the device's safety guard just before injection, demonstrating proper placement for administration.*
FDA Label Image

Figure (Ada08 0006 42)

Figure (Ada08 0006 42)
An instructional illustration showing a hand holding a subcutaneous injection device with a safety guard. A close-up inset highlights the safety guard before injection, and a downward arrow indicates the injection direction into the skin.*
FDA Label Image

Figure (Ada08 0006 43)

Figure (Ada08 0006 43)
An instructional illustration showing a hand holding a syringe for subcutaneous injection. The image highlights pressing and holding the plunger during the injection process, with the needle inserted into the skin. The diagram emphasizes correct syringe handling technique.*
FDA Label Image

Figure (Ada08 0006 44)

Figure (Ada08 0006 44)
An instructional illustration showing how to administer a subcutaneous injection using a syringe. The image depicts a hand holding the syringe with a note to hold it in place for 5 more seconds after injection. The close-up inset highlights the syringe's plunger movement after injection into the skin.*
FDA Label Image

Figure (Ada08 0006 45)

Figure (Ada08 0006 45)
An instructional illustration showing a hand holding and pulling an injection device upwards from the skin. The image includes a close-up inset of the injection device tip, highlighting the subcutaneous injection process likely intended for the Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 46)

Figure (Ada08 0006 46)
An instructional illustration showing a hand holding a cotton ball or pad, pressing it onto the skin surface. The image is labeled 'Figure U' and likely demonstrates the step of cleaning or preparing the skin before an injection for the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 47)

Figure (Ada08 0006 47)
Instructional graphic titled 'Step 7 Dispose of your prefilled pens' with a blue and yellow arrow design, showing guidance on disposal steps for prefilled pens in a subcutaneous drug kit.*
FDA Label Image

Figure (Ada08 0006 48)

Figure (Ada08 0006 48)
An illustration showing a hand disposing of a syringe or pen device into a red sharps disposal container with a lid and an open slot for safe needle disposal. This likely relates to the use or disposal instructions for Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 49)

Figure (Ada08 0006 49)
Instructional banner showing Step 8 for an injection process, advising to document the injection site and the date administered. The background includes a blue arrow with the text "Step 8" and the instruction next to it on a white and blue gradient background.*
FDA Label Image

Figure (Ada08 0006 50)

Figure (Ada08 0006 50)
An instructional illustration showing a hand holding a pen and writing the date of administration "11/24/22" and the injection site "Left thigh" on a lined note. The figure is labeled as "Figure W" and is designed to help users record injection details.*
FDA Label Image

Fresenius Kabi Logo (Ada08 0006 51)

FDA Label Image

Figure (Ada08 0006 52)

Figure (Ada08 0006 52)
An instructional image for Adalimumab-aacf (adalimumab) subcutaneous injection. It shows a single-dose prefilled syringe containing 40 mg/0.8 mL of medication, labeled as the IDACIO product, designed for subcutaneous use.*
FDA Label Image

Figure (Ada08 0006 53)

Figure (Ada08 0006 53)
Illustration showing a prefilled syringe kit of Adalimumab-aacf for subcutaneous use. The diagram labels parts of the syringe before use, including the needle cap, clear needle guard, liquid-filled syringe barrel, finger grip, and plunger. It also shows the syringe back view with a clear window. After use, the image depicts the needle covered by the needle guard with its spring extended, ensuring safe needle protection.*
FDA Label Image

Figure (Ada08 0006 54)

Figure (Ada08 0006 54)
An instructional graphic panel labeled 'Step 1 Prepare for your injection' with text on a blue gradient background highlighted by a yellow arrow, indicating the first step in a process likely related to using the Adalimumab-aacf kit for subcutaneous injection preparation.*
FDA Label Image

Figure (Ada08 0006 55)

Figure (Ada08 0006 55)
An illustration showing components of a subcutaneous injection kit including three white cotton balls, a folded white gauze pad, and a red plastic sharps disposal container with a white lid, as labeled 'Figure D.' The kit components are arranged on a white surface.*
FDA Label Image

Figure (Ada08 0006 56)

Figure (Ada08 0006 56)
An illustration showing a hand holding a kit box labeled with an expiration date, indicated by a zoomed-in circular overlay. An arrow points from the kit box to a refrigerator, suggesting storage instructions for the Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 57)

Figure (Ada08 0006 57)
An instructional illustration labeled 'Figure F' showing a hand lifting a kit component upward from a tray. The kit appears to be a medical device or drug delivery system, consistent with a subcutaneous injection kit.*
FDA Label Image

Figure (Ada08 0006 58)

Figure (Ada08 0006 58)
An instructional illustration labeled Figure G showing a hand placing a rectangular box into a refrigerator. The image likely depicts storage instructions for the product Adalimumab-aacf kit, emphasizing refrigeration.*
FDA Label Image

Figure (Ada08 0006 59)

Figure (Ada08 0006 59)
Illustration showing a syringe labeled for use with Adalimumab-aacf, a human prescription drug for subcutaneous injection. The image indicates to wait 30 minutes after injection, emphasizing a specific step in the administration process for this kit product from Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 60)

Figure (Ada08 0006 60)
An instructional graphic panel displaying the step number 'Step 2' in a highlighted yellow arrow followed by the text 'Check your prefilled syringe' on a blue background. This suggests part of a usage or preparation instruction process for a medication kit.*
FDA Label Image

Figure (Ada08 0006 61)

Figure (Ada08 0006 61)
Adalimumab-aacf kit for subcutaneous use, labeled with the generic name adalimumab. The label includes a space for the expiration date (EXP: YYYY-MM) and depicts a syringe vial marked with the product identifier Adalimumab-aacf. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 62)

Figure (Ada08 0006 62)
Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC, featuring a prefilled syringe with a clear barrel and a yellow plunger and cap. The syringe is labeled with dosing information and the product name.*
FDA Label Image

Figure (Ada08 0006 63)

Figure (Ada08 0006 63)
Adalimumab-aacf kit packaging label showing a syringe and the product label with the name Adalimumab-aacf. The kit is designed for subcutaneous use and labeled by Fresenius Kabi USA, LLC. The image includes product identification components such as the syringe and information label.*
FDA Label Image

Figure (Ada08 0006 64)

Figure (Ada08 0006 64)
An instructional diagram showing two subcutaneous injection devices or syringe caps side by side. The left device has a red X below it, indicating incorrect usage or capping. The right device has a green check mark, indicating correct usage or capping. The image is labeled "Figure L."*
FDA Label Image

Figure (Ada08 0006 65)

Figure (Ada08 0006 65)
Packaging label for Adalimumab-aacf kit, a subcutaneous human prescription drug. The label includes the proprietary name Adalimumab-aacf and is produced by Fresenius Kabi USA, LLC. A portion of the NDC number and a barcode are partially visible on the label.*
FDA Label Image

Figure (Ada08 0006 66)

Figure (Ada08 0006 66)
An instructional banner showing Step 3 of a process, instructing the viewer to wash their hands. The text is displayed in bold yellow and white on a blue and white gradient background with a right-pointing arrow.*
FDA Label Image

Figure (Ada08 0006 67)

Figure (Ada08 0006 67)
An instructional illustration showing a hand holding a syringe-like device under running water from a faucet, demonstrating cleaning or preparation for use, likely related to an injection process.*
FDA Label Image

Figure (Ada08 0006 68)

Figure (Ada08 0006 68)
Instructional panel labeled 'Step 4 Choose the injection site' in a combination of blue and yellow colors, likely part of a multi-step guide for using the Adalimumab-aacf subcutaneous injection kit.*
FDA Label Image

Figure (Ada08 0006 69)

Figure (Ada08 0006 69)
An instructional illustration showing the recommended injectable areas on a human body for subcutaneous administration. The marked areas include the abdomen and the front of both thighs, indicated by shaded regions with arrows pointing to them, labeled as "Injectable Areas".*
FDA Label Image

Figure (Ada08 0006 70)

Figure (Ada08 0006 70)
Illustration panel labeled Step 5 instructing to clean the injection site, likely part of an instructional series for administering a subcutaneous injection kit.*
FDA Label Image

Figure (Ada08 0006 71)

Figure (Ada08 0006 71)
An instructional diagram labeled 'Figure P' showing a hand holding a white wipe or pad, applying it to the skin, demonstrating a preparatory step for a subcutaneous injection.*
FDA Label Image

Figure (Ada08 0006 72)

Figure (Ada08 0006 72)
An instructional banner showing Step 6 of a process, labeled 'Give your injection,' with a blue gradient background and highlighted text emphasizing the step number and instructions.*
FDA Label Image

Figure (Ada08 0006 73)

Figure (Ada08 0006 73)
An instructional illustration showing two hands preparing a syringe for injection, with a blue arrow indicating the removal of the syringe cover. The syringe is labeled, but specific product text is not fully legible in the image.*
FDA Label Image

Figure (Ada08 0006 74)

Figure (Ada08 0006 74)
Illustration showing a human hand holding a subcutaneous injection kit, demonstrating the preparation of a syringe with a yellow plunger. The figure is labeled as 'Figure R'. This image likely depicts the use or handling of the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 75)

Figure (Ada08 0006 75)
Illustration showing the proper technique for administering a subcutaneous injection into the skin on the forearm or hand area. The image depicts a hand gently pinching the skin to prepare for the injection site. This instructional diagram supports the subcutaneous route for drug delivery, relevant to products like Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 76)

Figure (Ada08 0006 76)
Illustration showing the correct technique for subcutaneous injection with the needle held at a 45-degree angle to the skin, demonstrating how to administer the injection with a syringe on the forearm.*
FDA Label Image

Figure (Ada08 0006 77)

Figure (Ada08 0006 77)
An instructional illustration showing the use of the Adalimumab-aacf kit. The image depicts a hand holding a prefilled syringe with the needle cap being removed, directed by an arrow, preparing for subcutaneous injection into another hand below.*
FDA Label Image

Figure (Ada08 0006 78)

Figure (Ada08 0006 78)
An instructional illustration showing the use of the Adalimumab-aacf subcutaneous injection kit. The image depicts a hand administering an injection with a pen-like device into the skin, with an inset showing a close-up of the injection pen. The figure is labeled as Figure V.*
FDA Label Image

Figure (Ada08 0006 79)

Figure (Ada08 0006 79)
An illustration depicting a hand holding a cotton ball or gauze pad against a person's skin, likely demonstrating a step in subcutaneous injection or wound care. The image is labeled "Figure W."*
FDA Label Image

Figure (Ada08 0006 80)

Figure (Ada08 0006 80)
Instructional graphic showing Step 7: Dispose of used prefilled syringes. The graphic features a yellow arrow pointing right on a blue gradient background with white text giving the disposal instruction.*
FDA Label Image

Figure (Ada08 0006 81)

Figure (Ada08 0006 81)
An instructional illustration showing a hand holding a syringe with a yellow plunger above a red sharps disposal container with a white lid and a slot for syringe disposal. A blue downward arrow indicates that the syringe should be inserted into the container's slot for safe disposal.*
FDA Label Image

Figure (Ada08 0006 82)

Figure (Ada08 0006 82)
Instructional banner labeled Step 8, advising to document the injection site and date administered, part of an injection or medication administration guide.*
FDA Label Image

Figure (Ada08 0006 83)

Figure (Ada08 0006 83)
An instructional illustration showing a form titled 'Record the date and injection site,' with handwritten example entries for 'Date of administration: 11/24/22' and 'Injection site: Left thigh.' A hand holding a blue pen is shown writing on the form.*
FDA Label Image

Figure (Ada08 0006 84)

FDA Label Image

Figure (Ada08 0006 85)

Figure (Ada08 0006 85)
Instructions for use of Adalimumab-aacf starter package, a subcutaneous injection delivered via a 40 mg/0.8 mL single-dose prefilled pen. The text highlights that the product is IDACIO (adalimumab-aacf) and advises users to refer to the Starter Schedule inside the cover for the number of prefilled pens to use and timing as prescribed by a healthcare provider.*
FDA Label Image

Figure (Ada08 0006 86)

Figure (Ada08 0006 86)
An instructional illustration of the Adalimumab-aacf prefilled pen kit showing labeled parts before and after use. Key components include the needle cap, transparent syringe housing, syringe plunger, label area with product details, injector body, injection button, needle, and extended safety guard. The diagram distinguishes the pen's configuration prior to and following injection.*
FDA Label Image

Figure (Ada08 0006 87)

Figure (Ada08 0006 87)
Instructional banner titled 'Step 1 Prepare for your injection' in white text on a blue background with yellow accents. It advises users to refer to the Starter Schedule for the number of prefilled pens to administer and includes a small graphic of an open box with instructions.*
FDA Label Image

Figure (Ada08 0006 88)

Figure (Ada08 0006 88)
An illustration showing a red sharps disposal container with a secure lid, accompanied by three cotton balls and a white gauze pad. This image likely represents supplies included or used with the Adalimumab-aacf subcutaneous injection kit from Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 89)

Figure (Ada08 0006 89)
An instructional illustration showing a hand removing a kit box, labeled as Figure D, from a refrigerator. The image visually indicates the proper storage or handling method for the kit product.*
FDA Label Image

Figure (Ada08 0006 90)

Figure (Ada08 0006 90)
An instructional illustration labeled Figure E, showing a close-up of a kit box with an expiration date placeholder labeled 'EXP: YYYY-MM' on a circular sticker or label, indicating where the expiration date is displayed on the product packaging.*
FDA Label Image

Figure (Ada08 0006 91)

Figure (Ada08 0006 91)
An instructional illustration showing hands interacting with a device or kit component, with an upward-pointing arrow indicating the removal or lifting action of a part within the kit.*
FDA Label Image

Figure (Ada08 0006 92)

Figure (Ada08 0006 92)
Illustration showing a hand placing a rectangular box labeled as a kit into a refrigerator, depicting storage instructions for Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 93)

Figure (Ada08 0006 93)
Illustration showing a subcutaneous injection device with a circular timer indicating a 30-minute wait period. The image is labeled as Figure H and suggests waiting 30 minutes after preparation or injection, likely as part of administration instructions for Adalimumab-aacf kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 94)

Figure (Ada08 0006 94)
An instructional graphic labeled "Step 2 Wash your hands" featuring a blue background with yellow and white text, likely part of a step-by-step guide for medication preparation or administration.*
FDA Label Image

Figure (Ada08 0006 95)

Figure (Ada08 0006 95)
Illustration showing a pair of hands washing under a running faucet, emphasizing hand hygiene. The image likely serves as a step in instructions related to the use of the Adalimumab-aacf subcutaneous injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 96)

Figure (Ada08 0006 96)
An instructional banner labeled 'Step 3' with the text 'Check your prefilled pen' on a blue gradient background, guiding users to verify their medication delivery device during administration of Adalimumab.*
FDA Label Image

Figure (Ada08 0006 97)

Figure (Ada08 0006 97)
An illustration showing a transparent syringe housing labeled as Figure J. The image likely portrays a component related to the packaging or delivery system of the Adalimumab-aacf subcutaneous kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 98)

Figure (Ada08 0006 98)
Adalimumab-aacf kit for subcutaneous use by Fresenius Kabi USA, LLC. The image shows two labeled syringe kits with yellow caps. The kits are identified by the name Adalimumab-aacf and include expiration date and lot number fields displayed in callouts.*
FDA Label Image

Figure (Ada08 0006 99)

Figure (Ada08 0006 99)
An instructional diagram segment labeled 'Step 4' with text directing to choose the injection site for administering the medication, relevant to the use of Adalimumab-aacf kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 100)

Figure (Ada08 0006 100)
An instructional illustration showing recommended subcutaneous injectable areas on the human body for Adalimumab-aacf. Highlighted sites include the abdomen and the front part of both thighs, marked as suitable injection locations for subcutaneous administration.*
FDA Label Image

Figure (Ada08 0006 101)

Figure (Ada08 0006 101)
An instructional illustration labeled 'Figure M' showing a hand administering a subcutaneous injection into the thigh area. The image demonstrates the proper technique for injecting the medication under the skin, consistent with the subcutaneous route for the Adalimumab-aacf kit.*
FDA Label Image

Figure (Ada08 0006 102)

Figure (Ada08 0006 102)
Instructional image labeled Step 5; it instructs to clean the injection site prior to administration.*
FDA Label Image

Figure (Ada08 0006 103)

Figure (Ada08 0006 103)
Illustration showing an instruction step labeled 'Step 6' with the direction 'Give your injection' indicating it is part of a multi-step guide, likely related to using the Adalimumab-aacf subcutaneous injection kit.*
FDA Label Image

Figure (Ada08 0006 104)

Figure (Ada08 0006 104)
Illustration showing two hands demonstrating the removal of a cap from a prefilled syringe or pen, indicated by a blue arrow pointing upward. The image is labeled as Figure N and appears to instruct on preparing the Adalimumab-aacf subcutaneous injection kit for use.*
FDA Label Image

Figure (Ada08 0006 105)

Figure (Ada08 0006 105)
An illustration showing a hand holding the syringe-like autoinjector device for Adalimumab-aacf, a subcutaneous injection kit by Fresenius Kabi USA, LLC. The image is labeled as Figure O.*
FDA Label Image

Figure (Ada08 0006 106)

Figure (Ada08 0006 106)
An instructional illustration showing a hand holding a subcutaneous injection device at a 90-degree angle before injection. The image highlights the safety guard and the needle area with a close-up view labeled 'Before injection Figure P.' This diagram is related to the use of Adalimumab-aacf injection kit by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Ada08 0006 107)

Figure (Ada08 0006 107)
An instructional illustration showing how to use a prefilled syringe for subcutaneous injection. It features a hand holding the syringe vertically with the needle pointing downward, moving toward the skin. The image highlights the 'Safety guard' on the syringe, emphasizing its position before injection.*
FDA Label Image

Figure (Ada08 0006 108)

Figure (Ada08 0006 108)
An instructional illustration showing the use of a subcutaneous injection device, depicting a hand holding a syringe with a plunger being pressed down into the skin. A zoomed-in inset highlights the action of watching and holding the plunger during injection. The diagram is intended to demonstrate the proper injection technique for administering medication via subcutaneous route.*
FDA Label Image

Figure (Ada08 0006 109)

Figure (Ada08 0006 109)
An instructional illustration demonstrating the subcutaneous injection of Adalimumab-aacf using a syringe. The image shows a hand holding the syringe at an angle to the injection site and includes an inset highlighting that the syringe should be held in place for 5 seconds after injection to ensure proper delivery.*
FDA Label Image

Figure (Ada08 0006 110)

Figure (Ada08 0006 110)
An instructional diagram illustrating the subcutaneous injection process of the Adalimumab-aacf kit. It shows a hand holding the injection device at a 90-degree angle to the skin with an arrow indicating upward movement and includes a detailed inset of the needle tip engaging the skin.*
FDA Label Image

Figure (Ada08 0006 111)

Figure (Ada08 0006 111)
An illustration depicting a hand applying a circular cotton pad or swab to the skin, demonstrating a step in a procedure involving topical application or cleaning of the area. The image is labeled as Figure U.*
FDA Label Image

Figure (Ada08 0006 112)

Figure (Ada08 0006 112)
Instructional step labeled 'Step 7' indicating to dispose of prefilled pens. The graphic uses blue and yellow colors with the text 'Dispose of your prefilled pens' on a gradient background.*
FDA Label Image

Figure (Ada08 0006 113)

Figure (Ada08 0006 113)
An instructional illustration showing a hand placing a used syringe into a red sharps disposal container, indicating proper disposal of medical sharps. The image includes a downward arrow to guide the direction of insertion and is labeled as Figure V.*
FDA Label Image

Figure (Ada08 0006 114)

Figure (Ada08 0006 114)
Instructional banner labeled 'Step 8' in blue and yellow, directing to document the injection site and date administered. The background gradient transitions from blue to white, emphasizing the instruction for injection record keeping.*
FDA Label Image

Figure (Ada08 0006 115)

Figure (Ada08 0006 115)
An instructional illustration showing a hand holding a blue pen and writing the date and injection site on a lined notecard. The example text records 'Date of administration: 11/24/22' and 'Injection site: Left thigh,' with the heading 'Record the date and injection site' above the notecard. The figure is labeled as Figure W.*
FDA Label Image

Figure (Ada08 0006 116)

FDA Label Image

Principal Display Panel – 40 mg/0.8 mL Injection (Ada08 0006 117)

Principal Display Panel – 40 mg/0.8 mL Injection (Ada08 0006 117)
Packaging label for Adalimumab-aacf injection kit containing 2 single-dose prefilled pens. Each pen delivers 40 mg of adalimumab in 0.8 mL for subcutaneous use. The carton includes alcohol preps, prescribing information, medication guide, and instructions for use. Labeler: Fresenius Kabi USA, LLC.*
FDA Label Image

Principal Display Panel – 0.8 mL Single-dose Prefilled Pen Label (Ada08 0006 118)

Principal Display Panel – 0.8 mL Single-dose Prefilled Pen Label (Ada08 0006 118)
Label for Adalimumab-aacf injection, 40 mg/0.8 mL, a subcutaneous human prescription drug kit. The label includes a barcode, lot and expiration date fields, and the NDC number 65219-610-02. The product is labeled by Fresenius Kabi USA, LLC with US License No. 2146.*
FDA Label Image

Principal Display Panel – 0.8.ml (4 unit Starter Pack Carton Label)

Principal Display Panel – 0.8.ml (4 unit Starter Pack Carton Label)
Adalimumab-aacf 40 mg / 0.8 mL starter pack kit for subcutaneous injection, containing 4 single-dose prefilled pens. The packaging indicates use for Plaque Psoriasis and Uveitis and includes detailed storage instructions. Labeler is Fresenius Kabi USA, LLC. The carton features usage information, a medication guide note, and a barcode.*
FDA Label Image

Principal Display Panel – 0.8.ml (6 unit Starter Pack Carton Label)

Principal Display Panel – 0.8.ml (6 unit Starter Pack Carton Label)
Adalimumab-aacf 40 mg / 0.8 mL starter pack carton for injection by Fresenius Kabi USA, LLC. Contains 6 single-dose prefilled pens with 29 gauge needles for subcutaneous use. Includes patient and medication guides, alcohol preps, and instructions. Indicated for Crohn's Disease, Ulcerative Colitis, and Hidradenitis Suppurativa. Contains no preservatives; storage and usage instructions are provided.*
FDA Label Image

Principal Display Panel – 0.8.ml – 2 Pack Prefilled Syringe Carton Label (Ada08 0006 121)

Principal Display Panel – 0.8.ml – 2 Pack Prefilled Syringe Carton Label (Ada08 0006 121)
Packaging label for Adalimumab-aacf injection kit, containing 2 single-dose prefilled syringes of 40 mg/0.8 mL each. The kit is for subcutaneous use and includes two syringes with 29 gauge needles. Manufactured by Fresenius Kabi USA, LLC, the carton gives storage instructions, ingredient details, and warns to keep refrigerated and protected from light.*
FDA Label Image

Principal Display Panel –40 mg/ 0.8 mL Single-dose Prefilled Syringe Label (Ada08 0006 122)

Principal Display Panel –40 mg/ 0.8 mL Single-dose Prefilled Syringe Label (Ada08 0006 122)
Label for Adalimumab-aacf Injection 40 mg/0.8 mL kit by Fresenius Kabi USA, LLC. The label includes the NDC number 65219-618-02, dosage strength, and a barcode, as well as lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.